Parexel expands CRA training program; Recipharm inks a 10-year deal;

> Parexel International ($PRXL) has expanded its academy program in Japan, partnering with Kyoto Pharmaceutical University to train future clinical researchers. More

> BioClinica added health IT outfit Vitrana to its network of eClinical app developers, tapping the company's capabilities in processing adverse event reports. Item

> Recipharm signed a 10-year contract extension with South Korean drugmaker Daewoong worth €25 million ($27 million). Release

Suggested Articles

Genesis Drug Discovery & Development has bought up New England Discovery Partners as it looks to boost its synthetic and medicinal chemistry.

Sanofi plans to incorporate its real-world data platform with Aetion’s analytics system to better develop studies for regulatory decision-making.

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.